Amdocs Limited reported $5.00B of revenue over the trailing twelve months, +2.4% on the year before. 11 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $5.00B (to FY2024). Net Income: $493M, trailing twelve months to FY2024. Free Cash Flow: $619M, trailing twelve months to FY2024. Op Margin: 13%, trailing twelve months to FY2024.

DOXAmdocs Limited

TechnologyUSD

$59.96

$49.8752 weeks$86.36

On our screens:Stocks with no debt

DOX as reported

Amdocs Limited reported $5.00B of revenue over the trailing twelve months, +2.4% on the year before. 11 reported series are charted on this page, each one as filed.

$5.00B

Revenue, trailing twelve months · to FY2024 · +2.4% against the twelve months before

Net Income: $493M
Net Income · −8.8% year on year · trailing twelve months to FY2024
Free Cash Flow: $619M
Free Cash Flow · −11% year on year · trailing twelve months to FY2024
Op Margin: 13%
Op Margin · trailing twelve months to FY2024

Every series Ryufin has for DOX, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$5.00B	+2.4%	FY2024
Net Income	$493M	−8.8%	FY2024
EPS	$4.25	−5.3%	FY2024
Gross Margin	35%	n/a	FY2024
Op Margin	13%	n/a	FY2024
Net Margin	9.9%	n/a	FY2024
ROE	14%	n/a	FY2024
ROA	7.7%	n/a	FY2024
ROIC	14%	n/a	FY2024
Free Cash Flow	$619M	−11%	FY2024
P/E	14.1	n/a	today